Legal Representation
Attorney
Talivaldis Cepuritis
USPTO Deadlines
Application History
7 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 13, 2002 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| May 9, 2002 | CNRT | O | NON-FINAL ACTION MAILED | Loading... |
| Apr 30, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 31, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 11, 2001 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Jul 2, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 28, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 001
DIAGNOSTIC PREPARATIONS FOR SCIENTIFIC OR RESEARCH USE; DIAGNOSTIC PREPARATIONS, NAMELY, PREPARATIONS OF EXTRACTS, ASSAYS, NUCLEIC ACIDS, PROTEINS, POLYPEPTIDES, AND ANTIBODIES, AND MOLECULAR ARRAYS OR BIOLOGICAL MATERIALS FOR SCIENTIFIC OR RESEARCH USE
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
PHARMACEUTICAL PREPARATIONS FOR USE IN THE DIAGNOSIS OR TREATMENT OF HUMAN DISEASES AND DISORDERS, NAMELY, CIRCULATORY, RESPIRATORY, ENDOCRINE, NEUROLOGIC, CARDIOVASCULAR, ALIMENTARY, ONCOLOGIC, AUTO-IMMUNE OR IMMUNE-RELATE, PULMONARY, MUSCULOSKELETAL, LYMPHATIC, GASTROINTESTINAL, BONE, SENSORY, VIRAL, URINARY, RENAL, INFECTIOUS, METABOLIC OR CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS; DIAGNOSTIC ASSAYS AND TEST KITS FOR CLINICAL, LABORATORY, MEDICAL AND CHEMICAL USE TO DIAGNOSE, PROGNOSE, PREDICT OR TREAT DISEASES AND FOR PROVIDING GENOMIC AND PROTEOMIC PROFILES USEFUL IN THE SELECTION OF THERAPEUTICS; ASSAYS AND TEST KITS FOR EVALUATING EFFICACY OR TREATMENTS AND TREATMENT PROGRESS; PROGNOSTIC TEST KITS FOR IDENTIFYING HEREDITARY RISK FACTORS; DIAGNOSTIC PREPARATIONS, NAMELY, PREPARATIONS OF EXTRACTS, ASSAYS, NUCLEIC ACIDS, PROTEINS, POLYPEPTIDES, AND ANTIBODIES, AND MOLECULAR ARRAYS OR BIOLOGICAL MATERIALS FOR CLINICAL OR MEDICAL LABORATORY USE; DIAGNOSTIC PREPARATIONS FOR CLINICAL FOR MEDICAL LABORATORY USE
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
RESEARCH AND DEVELOPMENT SERVICES RENDERED TO OTHERS FOR DISCOVERING SMALL-MOLECULE DRUGS, ANTIBODIES, ANTISENSE DRUGS, PEPTIDES, PROTEINS AND GENE THERAPY DRUGS; MEDICAL AND DIAGNOSTIC SERVICES, NAMELY, DIAGNOSING, PREVENTING, AND PREDICTING DISEASE, IDENTIFYING HEREDITARY RISK FACTORS, DIAGNOSTIC TESTING, PROGNOSTIC TESTING, GENE AND PROTEIN TESTING, IDENTIFYING PHYSIOLOGICAL CHARACTERISTICS, ESTABLISHING INDIVIDUAL PREVENTATIVE PROGRAMS, ESTABLISHING DISEASE TREATMENTS BASED ON GENE AND PROTEIN EXPRESSION AND/OR ACTIVITY, EVALUATING CLINICAL TRIAL PROGRESS, DRUG MONITORING AND COMPUTER TRACKING OF A PATIENT'S HEALTH PROGRESS
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005
042